Preemptive Use of Oral Ganciclovir to Prevent Cytomegalovirus Infection in Liver Transplant Patients: A Randomized, Placebo‐Controlled Trial
Open Access
- 1 April 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 185 (7) , 854-860
- https://doi.org/10.1086/339449
Abstract
The use of postdetection antiviral treatment of cytomegalovirus (CMV) as a strategy to prevent infection and disease in solid-organ transplant patienKeywords
This publication has 0 references indexed in Scilit: